ST金時(002951.SZ):擬參設長卿創業 間接參與半導體及新材料領域的項目投資
格隆匯12月19日丨ST金時(002951.SZ)公佈,公司擬以有限合夥人身份通過認繳寧波梅山保税港區久科投資管理有限公司(簡稱“久科投資”)發起設立湖州百越長卿創業投資合夥企業(有限合夥)(簡稱“長卿創業”或“合夥企業”)合計1億元份額(最終合計份額以實際募集情況為準)中的1000萬元,間接參與半導體及新材料領域的項目投資。合夥企業已於2023年3月16日設立完成。
基金擬投資於航空航天、集成電路、軍工裝備、電子信息、健康醫療、先進製造等行業的未上市企業股權。閒置資金可投資於現金,銀行存款,銀行理財產品。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.